Bank of New York Mellon’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,072
| Closed | -$61.3K | – | 4314 |
|
|
2023
Q4 | $61.3K | Buy |
+1,072
| New | +$50.8K | ﹤0.01% | 4142 |
|
|
2021
Q2 | – | Sell |
-270
| Closed | -$63K | – | 4472 |
|
|
2021
Q1 | $63K | Sell |
270
-19
| -7% | -$7.68K | ﹤0.01% | 4226 |
|
|
2020
Q4 | $121K | Buy |
+289
| New | +$99.9K | ﹤0.01% | 4054 |
|
|
2020
Q2 | – | Sell |
-146
| Closed | -$150K | – | 4151 |
|
|
2020
Q1 | $150K | Buy |
146
+47
| +47% | +$68.5K | ﹤0.01% | 3807 |
|
|
2019
Q4 | $131K | Hold |
99
| – | – | ﹤0.01% | 3988 |
|
|
2019
Q3 | $137K | Buy |
99
+7
| +8% | +$11.3K | ﹤0.01% | 3977 |
|
|
2019
Q2 | $208K | Buy |
+92
| New | +$271K | ﹤0.01% | 3913 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | -$23K | – | 4287 |
|
|
2018
Q3 | $23K | Hold |
11
| – | – | ﹤0.01% | 4202 |
|
|
2018
Q2 | $29K | Sell |
11
-2
| -15% | -$5.27K | ﹤0.01% | 4147 |
|
|
2018
Q1 | $30K | Buy |
13
+1
| +8% | +$3K | ﹤0.01% | 4240 |
|
|
2017
Q4 | $50K | Buy |
12
+1
| +9% | +$4.2K | ﹤0.01% | 4208 |
|
|
2017
Q3 | $48K | Hold |
11
| – | – | ﹤0.01% | 4110 |
|
|
2017
Q2 | $49K | Sell |
11
-40
| -78% | -$169K | ﹤0.01% | 4136 |
|
|
2017
Q1 | $280K | Sell |
51
-5
| -9% | -$23.3K | ﹤0.01% | 3770 |
|
|
2016
Q4 | $251K | Buy |
56
+7
| +14% | +$87.2K | ﹤0.01% | 3828 |
|
|
2016
Q3 | $1.03M | Sell |
49
-4
| -8% | -$72.4K | ﹤0.01% | 3160 |
|
|
2016
Q2 | $815K | Buy |
53
+13
| +33% | +$297K | ﹤0.01% | 3273 |
|
|
2016
Q1 | $1.11M | Sell |
40
-2
| -5% | -$42.3K | ﹤0.01% | 2993 |
|
|
2015
Q4 | $1.2M | Buy |
42
+3
| +8% | +$98.9K | ﹤0.01% | 3042 |
|
|
2015
Q3 | $960K | Sell |
39
-1
| -3% | -$67.3K | ﹤0.01% | 3213 |
|
|
2015
Q2 | $3.35M | Buy |
40
+13
| +48% | +$1.19M | ﹤0.01% | 2596 |
|
|
2015
Q1 | $2.76M | Buy |
27
+1
| +4% | +$133K | ﹤0.01% | 2650 |
|
|
2014
Q4 | $3.41M | Sell |
26
-2
| -7% | -$146K | ﹤0.01% | 2521 |
|
|
2014
Q3 | $1.38M | Buy |
28
+11
| +65% | +$386K | ﹤0.01% | 3110 |
|
|
2014
Q2 | $457K | Buy |
17
+6
| +55% | +$141K | ﹤0.01% | 3633 |
|
|
2014
Q1 | $280K | Buy |
11
+2
| +22% | +$56.7K | ﹤0.01% | 3759 |
|
|
2013
Q4 | $243K | Hold |
9
| – | – | ﹤0.01% | 3803 |
|
|
2013
Q3 | $251K | Hold |
9
| – | – | ﹤0.01% | 3724 |
|
|
2013
Q2 | $350K | Buy |
+9
| New | +$338K | ﹤0.01% | 3621 |
|
Other funds holding TPST
IC
Bank of New York Mellon's TPST Position: Q1 2024 in Review
Bank of New York Mellon sold out of Tempest Therapeutics (TPST) in Q1 2024, closing a stake of 1,072 shares — an estimated $61.3K sold.
Bank of New York Mellon first reported a position in TPST in Q2 2013 and held it in 29 quarters. The position peaked at $3.41M in Q4 2014. 28 funds tracked by Wall St. Rank hold TPST as of Q1 2024.
- Bank of New York Mellon reported no remaining Tempest Therapeutics position as of Q1 2024 after selling out during the quarter.
- Bank of New York Mellon sold 1,072 Tempest Therapeutics shares in Q1 2024, an estimated $61.3K.
- Bank of New York Mellon first reported a position in Tempest Therapeutics in Q2 2013 and held it in 29 quarters.
- Bank of New York Mellon's Tempest Therapeutics position peaked at $3.41M in Q4 2014.
- 28 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2024.
Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.